Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clotting changes in borderline hypertension.

G M Patrassi1, F Fallo, A Santarossa

  • 1Second Chair of Medicine, University of Padua Medical School, Italy.

Journal of Human Hypertension
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease.

Computer methods and programs in biomedicine·2019
Same author

Type 2N von Willebrand disease: Characterization and diagnostic difficulties.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.

Thrombosis research·2015
Same author

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.

Thrombosis and haemostasis·2014
Same author

Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

Pituitary·2012
Same journal

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026
See all related articles

Patients with borderline hypertension show higher levels of Factor VIII and Factor XII, indicating activated coagulation. This suggests potential vascular changes occur before clinical signs appear.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Borderline hypertension is a precursor to sustained hypertension.
  • Early detection of vascular changes in borderline hypertension is crucial.
  • Coagulation factors play a role in vascular health and disease.

Purpose of the Study:

  • To investigate coagulation factor levels in patients with borderline hypertension.
  • To explore the relationship between coagulation activation and vascular wall interactions.
  • To identify potential early markers of vascular changes.

Main Methods:

  • Evaluated prothrombin time (PT) and partial thromboplastin time (PTT).
  • Measured Factor VIII coagulant activity, antigen, and ristocetin cofactor.

Related Experiment Videos

  • Assessed Factor XII and Factor XI activities.
  • Compared results against normal control groups.

    • Main Results:

    • Significantly higher Factor VIII coagulant activity, Factor XII, and PTT levels were observed in patients.
    • Factor VIII antigen and Factor XI activities were within normal limits.
    • PT was also within normal limits for both groups.

    Conclusions:

    • Elevated Factor VIII and Factor XII levels, with shortened PTT, suggest increased synthesis or release of these factors.
    • Activated coagulation may be present in borderline hypertension prior to clinical vascular lesions.
    • These findings highlight potential prothrombotic states in early hypertension.